Minnesota SF205 prohibits prior authorization for antineoplastic cancer treatment.

Minnesota SF205 amends state statutes to prohibit prior authorization for antineoplastic cancer treatment. This bill ensures that certain cancer treatments do not require prior authorization from health plans. Exceptions apply for medications used in cancer treatment, which must follow specific procedures for initial determinations and appeals. The changes take effect January 1, 2027, for health benefit plans offered, sold, issued, or renewed on or after that date.

Minnesota SF205 prohibits prior authorization for antineoplastic cancer treatment.

Minnesota SF205 amends state statutes to prohibit prior authorization for antineoplastic cancer treatment. This bill ensures that certain cancer treatments do not require prior authorization from health plans. Exceptions apply for medications used in cancer treatment, which must follow specific procedures for initial determinations and appeals. The changes take effect January 1, 2027, for health benefit plans offered, sold, issued, or renewed on or after that date.